JCR Pharmaceuticals Co., Ltd.

TSE:4552 株式レポート

時価総額:JP¥88.2b

JCR Pharmaceuticals 過去の業績

過去 基準チェック /06

JCR Pharmaceuticalsの収益は年間平均-0.3%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 増加しています。収益は年間4.3% 9.5%割合で 増加しています。

主要情報

-0.3%

収益成長率

-0.5%

EPS成長率

Pharmaceuticals 業界の成長3.4%
収益成長率9.5%
株主資本利益率-0.7%
ネット・マージン-1.2%
前回の決算情報30 Sep 2024

最近の業績更新

Recent updates

JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

Sep 06
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

What JCR Pharmaceuticals Co., Ltd.'s (TSE:4552) 32% Share Price Gain Is Not Telling You

Sep 04
What JCR Pharmaceuticals Co., Ltd.'s (TSE:4552) 32% Share Price Gain Is Not Telling You

JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

Aug 23
JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Aug 09
JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Earnings Miss: JCR Pharmaceuticals Co., Ltd. Missed EPS By 90% And Analysts Are Revising Their Forecasts

Aug 03
Earnings Miss: JCR Pharmaceuticals Co., Ltd. Missed EPS By 90% And Analysts Are Revising Their Forecasts

JCR Pharmaceuticals (TSE:4552) Will Pay A Dividend Of ¥10.00

Jul 26
JCR Pharmaceuticals (TSE:4552) Will Pay A Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

Jul 12
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

May 22
JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Mar 18
JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

Feb 29
JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

収支内訳

JCR Pharmaceuticals の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

TSE:4552 収益、費用、利益 ( )JPY Millions
日付収益収益G+A経費研究開発費
30 Sep 2435,256-43714,05811,234
30 Jun 2440,2084,09824,7080
31 Mar 2442,8715,50712,48511,234
31 Dec 2341,3655,36414,3218,802
30 Sep 2343,0348,06313,1728,802
30 Jun 2335,5454,01411,9218,802
31 Mar 2334,3433,77211,6788,802
31 Dec 2237,5085,15413,2677,175
30 Sep 2238,2806,23513,2527,175
30 Jun 2250,87514,34313,9437,175
31 Mar 2251,08214,50713,5117,175
31 Dec 2150,93116,54914,0715,360
30 Sep 2147,51714,89912,7715,360
30 Jun 2134,7177,65710,4835,360
31 Mar 2130,0856,8928,6245,360
31 Dec 2026,1284,1377,2435,997
30 Sep 2024,4962,9836,6855,997
30 Jun 2024,8073,0767,3965,997
31 Mar 2024,7812,6787,6385,997
31 Dec 1925,7093,6538,9094,354
30 Sep 1924,1213,2609,0004,354
30 Jun 1923,6383,8027,8024,354
31 Mar 1923,1603,7157,2714,354
31 Dec 1820,8742,4547,1774,211
30 Sep 1820,6822,5666,7454,211
30 Jun 1820,8852,8576,6424,211
31 Mar 1820,5943,0706,4704,211
31 Dec 1720,2332,9306,5024,071
30 Sep 1719,7382,7226,3874,071
30 Jun 1718,6702,0796,0954,071
31 Mar 1718,0851,8635,9204,071
31 Dec 1617,4831,6686,0613,348
30 Sep 1617,1901,7515,5113,348
30 Jun 1617,0911,6205,6183,348
31 Mar 1617,4381,7895,4783,348
31 Dec 1517,5942,2995,3833,334
30 Sep 1517,4822,2815,4053,334
30 Jun 1517,1921,8615,6783,334
31 Mar 1516,8551,6825,7133,334
31 Dec 1416,3801,0666,7922,202
30 Sep 1416,5161,3196,8952,202
30 Jun 1416,1171,3166,2802,202
31 Mar 1415,7051,2966,1162,202
31 Dec 1315,6691,5176,2691,991

質の高い収益: 4552は現在利益が出ていません。

利益率の向上: 4552は現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: 4552は利益が出ておらず、過去 5 年間で損失は年間0.3%の割合で増加しています。

成長の加速: 4552の過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: 4552は利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( 12.2% ) と比較することは困難です。


株主資本利益率

高いROE: 4552は現在利益が出ていないため、自己資本利益率 ( -0.71% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘